Lilium N.V. Secures $114 Million Financing

TL;DR

Lilium just raised $114M via stock offering and private placement to fund their eVTOL jet.

AI Summary

On May 24, 2024, Lilium N.V. announced a $114 million financing. This includes a $40 million underwritten public offering of 38,095,238 Class A ordinary shares and warrants, and a concurrent $50 million private placement. The company is based in Gauting, Germany.

Why It Matters

This financing provides Lilium with crucial capital to advance its electric vertical take-off and landing (eVTOL) jet aircraft development and commercialization efforts.

Risk Assessment

Risk Level: medium — The company is still in the development phase for its aircraft, and the success of this financing is critical for continued progress.

Key Numbers

• $114M — Total Financing (Capital raised through public offering and private placement.)
• $40M — Public Offering (Amount raised from the sale of shares and warrants.)
• $50M — Private Placement (Amount raised from the PIPE transaction.)

Key Players & Entities

• Lilium N.V. (company) — Registrant and issuer of securities
• 38,095,238 (dollar_amount) — Number of Class A ordinary shares and warrants in the public offering
• $40 million (dollar_amount) — Value of the underwritten public offering
• $50 million (dollar_amount) — Value of the concurrent private placement
• $114 million (dollar_amount) — Total financing amount
• May 24, 2024 (date) — Date of the financing announcement

FAQ

Key Financial Figures

• $114 million — the “Company”) announced a $114 million financing, including the pricing of a $
• $40 million — n financing, including the pricing of a $40 million underwritten public offering of 38,095,
• $50 million — rities”), as well as a concurrent $50 million private placement (the “PIPE&rdqu
• $350,000 — nd Engle agreed to invest approximately $350,000 in the PIPE. Additionally, pursuant to
• $1.05 — ,233,035 Shares at an exercise price of $1.05 per Share (the “Aceville Pre-Fund
• $24 m — dquo;) for an aggregate prepay price of $24 million, of which exercise price Aceville
• $1.00 — ville has agreed to partially prepay at $1.00 per Share against the total exercise pr
• $218 million — hat the Company will have approximately $218 million of cash available (calculated based on
• $110 million — d the PIPE. This reflects approximately $110 million of cash and cash equivalents and other
• $35 million — ets as of March 31, 2024, approximately $35 million of proceeds from the public offering, a
• $49 million — from the public offering, approximately $49 million of proceeds from the PIPE, and the $24
• $24 million — lion of proceeds from the PIPE, and the $24 million of gross proceeds from the Aceville Pre

Filing Documents

• tm2415530d1_6k.htm (6-K) — 16KB
• tm2415530d1_ex99-1.htm (EX-99.1) — 18KB
• 0001104659-24-064965.txt ( ) — 35KB

Forward-Looking Statements

Forward-Looking Statements The information contained in this Report on Form 6-K and the Exhibit attached hereto contain certain forward-looking statements within the meaning of the U.S. federal securities laws, including, but not limited to, statements regarding the consummation of the underwritten public offering, the PIPE and the Aceville Pre-Funding. These forward-looking statements generally are identified by words such as "proposed," "contemplates," "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions, projections, and other statements about future events that are based on management's current expectations with respect to future events and are based on assumptions and are subject to risks and uncertainties that are subject to change at any time. Actual events or results may differ materially from those contained in the forward-looking statements. Factors that could cause actual future events to differ materially from the forward-looking statements in this Report on Form 6-K and the Exhibit attached hereto include those risks and uncertainties discussed in Lilium's filings with the U.S. Securities and Exchange Commission (the "SEC"), including in the section titled "Risk Factors" in Lilium's Annual Report on Form 20-F for the year ended December 31, 2023, on file with the SEC, and similarly titled sections in Lilium's other SEC filings, all of which are available at www.sec.gov. Forward-looking statements speak only as of the date they are made. You are cautioned not to put undue reliance on forward-looking statements, and Lilium assumes no obligation to, and does not intend to, update, or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: May 24, 2024 Lilium N.V. By: /s/ Klaus Roewe Name: Klaus Roewe Title: Chief Executive Officer and Executive Director EXHIBIT INDEX Exhibit Number Description of Document 99.1 Press Release dated May 24, 2024

View Full Filing

View this 6-K filing on SEC EDGAR